Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Browse the detailed record of transactions filed by O'Grady Michael, Director General. Officer active across 2 companies, notably Northern Trust CORP. In total, 34 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €1.2m. Activity tracked since 5 May 2021. The latest transaction was filed on 24 April 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to O'Grady Michael
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
O'Grady Michael is Président, Directeur Général et Président du Conseil. He has 34 filings in total, and across the 34 sampled filings the reported activity consists of attributions, with EUR 1,220,260 of buys, EUR 0 of sells, between 2016-01-21 and 2026-04-28. The companies listed are Northern Trust CORP, where he is Chairman and CEO, and Abbott Laboratories, where he is Director.